Macrophage Responses to Multicore Encapsulated Iron Oxide Nanoparticles for Cancer Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Immunology

Background:

• Macrophages are crucial for processing nanoparticles and determining host immune responses.
• Understanding macrophage interactions with nanoparticles is vital for clinical safety assessments.
• Iron oxide multicore encapsulated nanoparticles (Sarah nanoparticles, SaNPs) are designed for magnetic hyperthermia cancer treatment.

Purpose of the Study:

• To investigate the cellular responses of murine RAW264.7 macrophages to SaNPs.
• To elucidate the mechanisms of nanoparticle uptake, degradation, and clearance by macrophages.
• To assess the immunological outcomes and potential antitumor effects of SaNP-activated macrophages.

Main Methods:

• Murine RAW264.7 macrophages were exposed to SaNPs.
• A wide imaging approach was used to study cellular responses.
• Analysis included nanoparticle internalization, localization, degradation, and clearance.
• Key immunological markers such as tumor necrosis factor alpha (TNF-α), reactive oxygen species (ROS), and cytokine secretion were evaluated.

Main Results:

• SaNPs were internalized and localized in lysosomes without toxic degradation, and were cleared over time.
• SaNP effects were dose- and time-dependent.
• High SaNP concentrations reduced cell viability, correlating with superoxide dismutase (SOD) activation and ROS generation.
• Lower SaNP concentrations stimulated TNF-α production and induced cytokine secretion, potentially mediating antitumor effects via conditioned medium.

Conclusions:

• SaNPs are biocompatible and cleared by macrophages without causing significant intracellular toxicity.
• SaNP-macrophage interactions elicit dose-dependent immune responses, including the production of cytokines that may contribute to antitumor activity.
• These findings provide crucial insights into nanoparticle fate and immunomodulation for safe clinical applications.